Guin D, et al. - This systematic review was performed to identify predictive genetic biomarkers for levodopa response (LR) and ascertain common molecular link with disease susceptibility. The researchers showed the genetically significant polymorphism concerning the adverse effects (ADRs) and levodopa efficacy. The 6 common genes could be used as predictive markers for therapy optimization and as putative drug target candidates.